Assignee
REMEGEN LTD
CN·3 granted patents·4 pending applications·7 citations·filing 2014–2024
Top patents by PatentIndex Score
7 records- 0177US10087260B2Anti-HER2 antibody and conjugate thereofREMEGEN LTD·Filed 2014·Granted Oct 2, 2018·7 cites·19 claims
- 0274US2025090682A1Anti-mesothelin antibody and antibody drug conjugate thereofREMEGEN LTD·Filed 2024·Application pending·0 cites
- 0365US12171840B2Anti-mesothelin antibody and antibody drug conjugate thereofREMEGEN LTD·Filed 2019·Granted Dec 24, 2024·0 cites·20 claims
- 0458US2020138968A1Process for preparing intermediate of antibody drug conjugateREMEGEN LTD·Filed 2019·Application pending·0 cites
- 0548US2021087253A1Application of taci-fc fusion protein in preparation of drugs for treating neuromyelitis optica spectrum disorders and multiple sclerosisREMEGEN LTD·Filed 2019·Application pending·0 cites
- 0648US2020289663A1Use of anti-her2 antibody-drug conjugate in treating urothelial carcinomaREMEGEN LTD·Filed 2019·Application pending·0 cites
- 0740US9957313B2FGFR-FC fusion proteins and the use thereofREMEGEN LTD·Filed 2016·Granted May 1, 2018·0 cites·8 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →